1. Kirby Institute. HIV in Australia: annual surveillance short report. Sydney: Kirby Institute, UNSW Sydney; 2018.
  2. Jin F, Prestage GP, Zablotska I, Rawstorne P, Kippax SC, Donovan B, et al. High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohorts. Sex Transm Infect. 2007;83(5):397-9.
  3. Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2018. Sydney: Kirby Institute, UNSW Sydney; 2018.
  4. Australasian Sexual Health Alliance. Australian STI Management Guidelines for use in primary care. Available from URL: (accessed 6 October 2019).
  5. Cohen MS, Council OD, Chen JS. Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. Journal of the International AIDS Society. 2019;22 Suppl 6:e25355.
  6. Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. The lancet HIV. 2018;5(8):e438-e47.
  7. Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet (London, England). 2019;393(10189):2428-38.
  8. Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. The lancet HIV. 2018;5(11):e629-e37.
  9. Lal L, Audsley J, Murphy DA, Fairley CK, Stoove M, Roth N, et al. Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users. AIDS (London, England). 2017;31(12):1709-14.
  10. Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, et al. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection. Jama. 2019;321(14):1380-90.
  11. Barbosa C, Macasaet M, Brockmann S, Sierra MF, Xia Z, Duerr A. Pelvic inflammatory disease and human immunodeficiency virus infection. Obstetrics and gynecology. 1997;89(1):65-70.
  12. New York State Department of Health AIDS Institute. Management of Gonorrhea and Chlamydia in Patients with HIV 2018. Available from URL: (accessed 6 October 2019).
  13. Kong FY, Tabrizi SN, Fairley CK, Vodstrcil LA, Huston WM, Chen M, et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy. 2015;70(5):1290-7.
  14. Lau A, Kong F, Fairley CK, Donovan B, Chen M, Bradshaw C, et al. Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol. BMC Infect Dis. 2017;17(1):35.
  15. de Vrieze NH, de Vries HJ. Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review. Expert Rev Anti Infect Ther. 2014;12(6):697-704.
  16. Bissessor M, Fairley CK, Read T, Denham I, Bradshaw C, Chen M. The etiology of infectious proctitis in men who have sex with men differs according to HIV status. Sex Transm Dis. 2013;40(10):768-70.
  17. Davies SC, Shapiro J, Comninos NB, Templeton DJ. Lymphogranuloma venereum presenting as penile ulcer in two HIV-negative gay men. Int J STD AIDS. 2019;30(5):515-8.
  18. Stark D, van Hal S, Hillman R, Harkness J, Marriott D. Lymphogranuloma venereum in Australia: anorectal Chlamydia trachomatis serovar L2b in men who have sex with men. J Clin Microbiol. 2007;45(3):1029-31.
  19. Templeton DJ, Grulich AE, Yew J, Twin J, Jin F, Prestage GP, et al. Lymphogranuloma venereum is rare in Australian community-based samples of men who have sex with men. Sex Transm Dis. 2011;38(1):48-9.
  20. Templeton DJ, Ressler KA, Hope K, Poynten IM. Enhanced surveillance of a lymphogranuloma venereum outbreak in Sydney 2010-2012. Aust N Z J Public Health. 2016;40(4):368-70.
  21. Templeton DJ, Sharp N, Gryllis S, O'Connor CC, Dubedat SM. Prevalence and predictors of lymphogranuloma venereum among men who have sex with men at a Sydney metropolitan sexual health clinic. Sex Health. 2013;10(2):190-1.
  22. de Vries HJC, de Barbeyrac B, de Vrieze NHN, Viset JD, White JA, Vall-Mayans M, et al. 2019 European guideline on the management of lymphogranuloma venereum. J Eur Acad Dermatol Venereol. 2019.
  23. Kendall BA, Tardif KD, Schlaberg R. Chlamydia trachomatis L serovars and dominance of novel L2b ompA variants, U.S.A. Sex Transm Infect. 2014;90(4):336.
  24. Castro R, Baptista T, Vale A, Nunes H, Prieto E, Araujo C, et al. Lymphogranuloma venereum serovar L2b in Portugal. Int J STD AIDS. 2010;21(4):265-6.
  25. Leeyaphan C, Ong JJ, Chow EP, Dimovski K, Kong FY, Hocking JS, et al. Treatment Outcomes for Rectal Lymphogranuloma Venereum in Men Who Have Sex with Men Using Doxycycline, Azithromycin, or Both: A Review of Clinical Cases. Sex Transm Dis. 2017;44(4):245-8.
  26. White JA. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis. 2009;22(1):57-66.
  27. Kotevski DP, Lam M, Selvey CE, Templeton DJ, Donovan L, Sheppeard V. Epidemiology of lymphogranuloma venereum in New South Wales, 2006-2015. Commun Dis Intell (accepted Sept 2019).
  28. Lin M, Roche P, Spencer J, Milton A, Wright P, Witteveen D, et al. Australia's notifiable diseases status, 2000. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep. 2002;26(2):118-203.
  29. de Vrieze NH, van Rooijen M, Schim van der Loeff MF, de Vries HJ. Anorectal and inguinal lymphogranuloma venereum among men who have sex with men in Amsterdam, The Netherlands: trends over time, symptomatology and concurrent infections. Sex Transm Infect. 2013;89(7):548-52.
  30. Childs T, Simms I, Alexander S, Eastick K, Hughes G, Field N. Rapid increase in lymphogranuloma venereum in men who have sex with men, United Kingdom, 2003 to September 2015. Euro Surveill. 2015;20(48):30076.
  31. de Voux A, Kent JB, Macomber K, Krzanowski K, Jackson D, Starr T, et al. Notes from the Field: Cluster of Lymphogranuloma Venereum Cases Among Men Who Have Sex with Men - Michigan, August 2015-April 2016. MMWR Morb Mortal Wkly Rep. 2016;65(34):920-1.
  32. Queensland Health. Notifiable conditions annual reporting. Available from URL: https://wwwhealthqldgovau/clinical-practice/guidelines-procedures/diseases-infection/surveillance/reports/notifiable/annual (accessed September 25 2019).
  33. NSW Health. NSW Sexually Transmissible Infections Strategy 2016-2020: Data Report January to December 2018. Available from URL: (accessed 25 Sept 2019).
  34. De Vrieze HNN, Versteeg MB, Bruisten SS, Van Rooijen JM, Van Der Helm JCJ, De Vries JCH. Low Prevalence of Urethral Lymphogranuloma Venereum Infections Among Men Who Have Sex With Men: A Prospective Observational Study, Sexually Transmitted Infection Clinic in Amsterdam, the Netherlands. Sexually Transmitted Diseases. 2017;44(9):547-50.
  35. Nieuwenhuis RF, Ossewaarde JM, Gotz HM, Dees J, Thio HB, Thomeer MG, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis. 2004;39(7):996-1003.
  36. Van der Bij AK, Spaargaren J, Morre SA, Fennema HS, Mindel A, Coutinho RA, et al. Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case-control study. Clin Infect Dis. 2006;42(2):186-94.
  37. Bax CJ, Quint KD, Peters RP, Ouburg S, Oostvogel PM, Mutsaers JA, et al. Analyses of multiple-site and concurrent Chlamydia trachomatis serovar infections, and serovar tissue tropism for urogenital versus rectal specimens in male and female patients. Sex Transm Infect. 2011;87(6):503-7.
  38. Versteeg B, van Rooijen MS, Schim van der Loeff MF, de Vries HJ, Bruisten SM. No indication for tissue tropism in urogenital and anorectal Chlamydia trachomatis infections using high-resolution multilocus sequence typing. BMC Infect Dis. 2014;14:464.
  39. Rank RG, Yeruva L. An alternative scenario to explain rectal positivity in Chlamydia-infected individuals. Clin Infect Dis. 2015;60(10):1585-6.
  40. Igietseme JU, Portis JL, Perry LL. Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae. Infect Immun. 2001;69(3):1832-40.
  41. Schachter J, Grossman M, Holt J, Sweet R, Spector S. Infection with Chlamydia trachomatis: involvement of multiple anatomic sites in neonates. J Infect Dis. 1979;139(2):232-4.
  42. de Vries HJ. The Enigma of Lymphogranuloma Venereum Spread in Men Who Have Sex With Men: Does Ano-Oral Transmission Plays a Role? Sex Transm Dis. 2016;43(7):420-2.
  43. Read PJ, McNulty A. Lymphogranuloma venereum presenting as genital ulceration and inguinal syndrome. Med J Aust. 2013;199(1):27-8.
  44. Chen MY, Read TR, Leslie DE, Bissessor M. A couplet: a case of anal ulceration and another of inguinal swelling. Med J Aust. 2011;195(1):47-8.
  45. Gallegos M, Bradly D, Jakate S, Keshavarzian A. Lymphogranuloma venereum proctosigmoiditis is a mimicker of inflammatory bowel disease. World J Gastroenterol. 2012;18(25):3317-21.
  46. Levy I, Gefen-Halevi S, Nissan I, Keller N, Pilo S, Wieder-Finesod A, et al. Delayed diagnosis of colorectal sexually transmitted diseases due to their resemblance to inflammatory bowel diseases. Int J Infect Dis. 2018;75:34-8.
  47. Nguyen V, Lee EY, Couldwell D, Packham D. Education and Imaging: gastrointestinal: outbreak; proctocolitis mimicking inflammatory bowel disease. J Gastroenterol Hepatol. 2012;27(11):1760.
  48. Patel S, Hay P. Lymphogranuloma venereum and HIV infection: misdiagnosed as Crohn's disease. BMJ Case Rep. 2010;2010.
  49. Ravens AF. Inflammatory bowel disease--be aware of the mimics. Diagnosis: lymphogranuloma venerum. Gut. 2006;55(3):333, 41.
  50. Rob F, Kaspirkova J, Juzlova K, Pesta M, Hercogova J. Lymphogranuloma venereum with only proximal rectal involvement mimicking inflammatory bowel disease: a potential diagnostic pitfall. J Eur Acad Dermatol Venereol. 2017;31(5):e264-e5.
  51. Soni S, Srirajaskanthan R, Lucas SB, Alexander S, Wong T, White JA. Lymphogranuloma venereum proctitis masquerading as inflammatory bowel disease in 12 homosexual men. Aliment Pharmacol Ther. 2010;32(1):59-65.
  52. Bancil AS, Alexakis C, Pollok R. Delayed diagnosis of lymphogranuloma venereum-associated colitis in a man first suspected to have rectal cancer. JRSM Open. 2016;8(1):2054270416660933.
  53. Crickx E, Meignin V, Gerard L, Plantier-Colcher I, Walker-Combrouze F, Boutboul D, et al. Rectal Lymphogranuloma Venereum in HIV-infected Patients Can Mimic Lymphoma. J Clin Gastroenterol. 2016;50(5):414-6.
  54. Hechtman JF, Dimaio CJ, Matloff J, Harpaz N, Zhu H. Rectal lymphogranuloma venereum mimicking cancer. Endoscopy. 2013;45 Suppl 2 UCTN:E315-6.
  55. Taylor G, Dasari BV, McKie L, Harvey C, Emerson C. Lymphogranuloma venerum (LGV) proctitis mimicking rectal cancer. Colorectal Dis. 2011;13(4):e63-4.
  56. De Baetselier I, Tsoumanis A, Verbrugge R, De Deken B, Smet H, Abdellati S, et al. Lymphogranuloma venereum is on the rise in Belgium among HIV negative men who have sex with men: surveillance data from 2011 until the end of June 2017. BMC Infect Dis. 2018;18(1):689.
  57. Saxon C, Hughes G, Ison C. Asymptomatic Lymphogranuloma Venereum in Men who Have Sex with Men, United Kingdom. Emerg Infect Dis. 2016;22(1):112-6.
  58. Haar K, Dudareva-Vizule S, Wisplinghoff H, Wisplinghoff F, Sailer A, Jansen K, et al. Lymphogranuloma venereum in men screened for pharyngeal and rectal infection, Germany. Emerg Infect Dis. 2013;19(3):488-92.
  59. Ward H, Alexander S, Carder C, Dean G, French P, Ivens D, et al. The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study. Sex Transm Infect. 2009;85(3):173-5.
  60. Rodriguez-Dominguez M, Puerta T, Menendez B, Gonzalez-Alba JM, Rodriguez C, Hellin T, et al. Clinical and epidemiological characterization of a lymphogranuloma venereum outbreak in Madrid, Spain: co-circulation of two variants. Clin Microbiol Infect. 2014;20(3):219-25.
  61. Zablotska IB, Holt M, de Wit J, Mao L, Down I, Prestage G. At home and away: gay men and high risk sexual practices. AIDS Behav. 2014;18(8):1436-42.
  62. Truong HM, Chen YH, Grasso M, Robertson T, Tao L, Fatch R, et al. HIV Serodisclosure and Sexual Behavior During International Travel. Sex Transm Dis. 2016;43(7):459-64.
  63. Taylor KD, Raymond HF, Truong HM, Ick T, Le B, Rive J, et al. International travel among HIV-positive and HIV-negative men who have sex with men, San Francisco, USA. Int J STD AIDS. 2011;22(10):568-70.
  64. Moodley P, Sturm PD, Vanmali T, Wilkinson D, Connolly C, Sturm AW. Association between HIV-1 infection, the etiology of genital ulcer disease, and response to syndromic management. Sex Transm Dis. 2003;30(3):241-5.
  65. Leeyaphan C, Ong JJ, Chow EP, Kong FY, Hocking JS, Bissessor M, et al. Systematic Review and Meta-Analysis of Doxycycline Efficacy for Rectal Lymphogranuloma Venereum in Men Who Have Sex with Men. Emerg Infect Dis. 2016;22(10):1778-84.
  66. Mechai F, de Barbeyrac B, Aoun O, Merens A, Imbert P, Rapp C. Doxycycline failure in lymphogranuloma venereum. Sex Transm Infect. 2010;86(4):278-9.
  67. Oud EV, de Vrieze NH, de Meij A, de Vries HJ. Pitfalls in the diagnosis and management of inguinal lymphogranuloma venereum: important lessons from a case series. Sex Transm Infect. 2014;90(4):279-82.
  68. Vall-Mayans M, Isaksson J, Caballero E, Salles B, Herrmann B. Bubonic lymphogranuloma venereum with multidrug treatment failure. Int J STD AIDS. 2014;25(4):306-8.
  69. Simons R, Candfield S, French P, White JA. Observed Treatment Responses to Short-Course Doxycycline Therapy for Rectal Lymphogranuloma Venereum in Men Who Have Sex With Men. Sex Transm Dis. 2018;45(6):406-8.
  70. Blanco JL, Fuertes I, Bosch J, Gonzalez A, Vergara A, Camp R, et al. Effective Treatment of Lymphogranuloma Venereum (LGV) With 1g Azithromycin Administered Weekly for 3 Weeks in an HIV-Infected Population. CROI, Seattle, 2015 (Abstract number 845).
  71. Bernstein K, Bowen VB, Kim CR, Counotte MJ, Kirkcaldy RD, Kara E, et al. Re-emerging and newly recognized sexually transmitted infections: Can prior experiences shed light on future identification and control? PLoS medicine. 2017;14(12):e1002474.
  72. Baumann L, Cina M, Egli-Gany D, Goutaki M, Halbeisen FS, Lohrer GR, et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis. Sex Transm Infect. 2018;94(4):255-62.
  73. Napierala Mavedzenge S, Weiss HA. Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis. AIDS (London, England). 2009;23(5):611-20.
  74. Manhart LE, Mostad SB, Baeten JM, Astete SG, Mandaliya K, Totten PA. High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. J Infect Dis. 2008;197(5):733-6.
  75. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61(3):418-26.
  76. Read TR, Fairley CK, Tabrizi SN, Bissessor M, Vodstrcil L, Chow EP, et al. Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance. Clin Infect Dis. 2017;64(3):250-6.
  77. Masha SC, Cools P, Sanders EJ, Vaneechoutte M, Crucitti T. Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2019;95(1):36-42.
  78. Graham S, Smith LW, Fairley CK, Hocking J. Prevalence of chlamydia, gonorrhoea, syphilis and trichomonas in Aboriginal and Torres Strait Islander Australians: a systematic review and meta-analysis. Sex Health. 2016;13(2):99-113.
  79. Kwon I, McNulty A, Read P. The prevalence of Trichomonas vaginalis detected by wet mount and polymerase chain reaction in Sydney women. Sex Health. 2013;10(4):385-6.
  80. Bygott JM, Robson JM. The rarity of Trichomonas vaginalis in urban Australia. Sex Transm Infect. 2013;89(6):509-13.
  81. Tilley DM, Dubedat SM, Lowe P, Templeton DJ. Genital Trichomonas vaginalis is rare among female attendees at a Sydney metropolitan sexual health clinic. Aust N Z J Public Health. 2016;40(1):95-6.
  82. Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009;36(1):11-6.
  83. Masese LN, Graham SM, Gitau R, Peshu N, Jaoko W, Ndinya-Achola JO, et al. A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy. BMC Infect Dis. 2011;11:307.
  84. Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis. 2002;34(4):519-22.
  85. Kelley CF, Rosenberg ES, O'Hara BM, Sanchez T, del Rio C, Sullivan PS. Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men. Sex Transm Dis. 2012;39(9):739.
  86. The Department of Health. 18th Multijurisdictional Syphilis Outbreak Surveillance Report. Australia2019.
  87. Australian Sexually Transmitted Infection & HIV Testing Guidelines for asymptomatic men who have sex with men 2019. Available from URL: (accessed 6 October 2019).
  88. Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis. 2004;4(7):456-66.
  89. Salazar JC, Cruz AR, Pope CD, Valderrama L, Trujillo R, Saravia NG, et al. Treponema pallidum elicits innate and adaptive cellular immune responses in skin and blood during secondary syphilis: a flow-cytometric analysis. J Infect Dis. 2007;195(6):879-87.
  90. Solomon MM, Mayer KH, Glidden DV, Liu AY, McMahan VM, Guanira JV, et al. Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial. Clin Infect Dis. 2014;59(7):1020-6.
  91. Buchacz K, Patel P, Taylor M, Kerndt PR, Byers RH, Holmberg SD, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. Aids. 2004;18(15):2075-9.
  92. Kofoed K, Gerstoft J, Mathiesen LR, Benfield T. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex Transm Dis. 2006;33(3):143-8.
  93. Palacios R, Jimenez-Onate F, Aguilar M, Galindo MJ, Rivas P, Ocampo A, et al. Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J Acquir Immune Defic Syndr. 2007;44(3):356-9.
  94. Sadiq ST, McSorley J, Copas AJ, Bennett J, Edwards SJ, Kaye S, et al. The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen. Sex Transm Infect. 2005;81(5):380-5.
  95. Lang R, Read R, Krentz HB, Peng M, Ramazani S, Vu Q, et al. A retrospective study of the clinical features of new syphilis infections in an HIV-positive cohort in Alberta, Canada. BMJ Open. 2018;8(7):e021544.
  96. Weintrob AC, Gu W, Qin J, Robertson J, Ganeson A, Crum-Cianflone NF, et al. Syphilis co-infection does not affect HIV disease progression. Int J STD AIDS. 2010;21(1):57-9.
  97. Rompalo AM, Joesoef MR, O'Donnell JA, Augenbraun M, Brady W, Radolf JD, et al. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis. 2001;28(3):158-65.
  98. Tucker JD, Shah S, Jarell AD, Tsai KY, Zembowicz A, Kroshinsky D. Lues maligna in early HIV infection case report and review of the literature. Sex Transm Dis. 2009;36(8):512-4.
  99. Tuddenham S, Ghanem KG. Neurosyphilis: Knowledge Gaps and Controversies. Sex Transm Dis. 2018;45(3):147-51.
  100. Marra CM. Neurosyphilis. Continuum (Minneap Minn). 2015;21(6 Neuroinfectious Disease):1714-28.
  101. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008;47(2):258-65.
  102. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Neurosyphilis in a clinical cohort of HIV-1-infected patients. Aids. 2008;22(10):1145-51.
  103. Marra CM, Maxwell CL, Tantalo LC, Sahi SK, Lukehart SA. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis. 2008;47(7):893-9.
  104. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines. In: Division of STD Prevention National Center for HIV/AIDS VH, STD, and TB Prevention, editor. Atlanta, Georgia: CDC; 2015.
  105. Kingston M, French P, Higgins S, McQuillan O, Sukthankar A, Stott C, et al. UK national guidelines on the management of syphilis 2015. Int J STD AIDS. 2016;27(6):421-46.
  106. Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, Eaton M, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis. 2004;189(3):369-76.
  107. Libois A, De Wit S, Poll B, Garcia F, Florence E, Del Rio A, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis. 2007;34(3):141-4.
  108. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009;48(6):816-21.
  109. Marks M, Lawrence D, Kositz C, Mabey D. Diagnostic performance of PCR assays for the diagnosis of neurosyphilis: a systematic review. Sex Transm Infect. 2018;94(8):585-8.
  110. Overview of management of syphilis [Internet]. Therapeutic Guidelines Ltd. 2019.
  111. Yang CJ, Lee NY, Lin YH, Lee HC, Ko WC, Liao CH, et al. Jarisch-Herxheimer reaction after penicillin therapy among patients with syphilis in the era of the hiv infection epidemic: incidence and risk factors. Clin Infect Dis. 2010;51(8):976-9.
  112. Butler T. The Jarisch-Herxheimer Reaction After Antibiotic Treatment of Spirochetal Infections: A Review of Recent Cases and Our Understanding of Pathogenesis. Am J Trop Med Hyg. 2017;96(1):46-52.
  113. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. The New England journal of medicine. 1997;337(5):307-14.
  114. Marra CM, Maxwell CL, Tantalo L, Eaton M, Rompalo AM, Raines C, et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis. 2004;38(7):1001-6.
  115. Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm Infect. 2006;82(2):164-8.
  116. Durukan D, Fairley CK, Bradshaw CS, Read TRH, Druce J, Catton M, et al. Increasing proportion of herpes simplex virus type 1 among women and men diagnosed with first-episode anogenital herpes: a retrospective observational study over 14 years in Melbourne, Australia. Sex Transm Infect. 2019;95(4):307-13.
  117. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. Aids. 2006;20(1):73-83.
  118. Nagot N, Ouedraogo A, Konate I, Weiss HA, Foulongne V, Defer MC, et al. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis. 2008;198(2):241-9.
  119. Nagot N, Ouedraogo A, Foulongne V, Konate I, Weiss HA, Vergne L, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med. 2007;356(8):790-9.
  120. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010;362(5):427-39.
  121. Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9630):2109-19.
  122. Mosunjac M, Park J, Wang W, Tadros T, Siddiqui M, Bagirov M, et al. Genital and perianal herpes simplex simulating neoplasia in patients with AIDS. AIDS Patient Care STDS. 2009;23(3):153-8.
  123. Yudin MH, Kaul R. Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy. Infect Dis Obstet Gynecol. 2008;2008:592532.
  124. Sbidian E, Battistella M, Legoff J, Lafaurie M, Bezier M, Agbalika F, et al. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy. Clin Infect Dis. 2013;57(11):1648-55.
  125. Kinghorn GR. Genital herpes: natural history and treatment of acute episodes. J Med Virol. 1993;Suppl 1:33-8.
  126. British Association of Sexual Health and HIV. UK National Guideline for the Management of Anogenital Herpes. 2014.
  127. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35(5):435-45.
  128. Bagdades EK, Pillay D, Squire SB, O'Neil C, Johnson MA, Griffiths PD. Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. Aids. 1992;6(11):1317-20.
  129. Ioannidis JP, Collier AC, Cooper DA, Corey L, Fiddian AP, Gazzard BG, et al. Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis. 1998;178(2):349-59.
  130. Mayaud P, Nagot N, Konate I, Ouedraogo A, Weiss HA, Foulongne V, et al. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Sex Transm Infect. 2008;84(5):332-7.
  131. Tan DH, Raboud JM, Kaul R, Walmsley SL. Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study. BMJ Open. 2014;4(1):e004210.
  132. Centres for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. In: Services USDoHH, editor. Atlanta, Georgia2014.